Provider review
OmniRx Health review
By The Dose Brief Desk · Updated
OmniRx Health advertises online weight care. Its homepage and New Jersey page show different starting amounts, so get a quote for the exact prescription.
Not rated. This review examines published program information; it is not a firsthand treatment review.
At a glance
- Semaglutide
- New Jersey page advertises from $299/mo. Formulation and total need confirmation.
- Tirzepatide
- New Jersey page advertises from $349/mo. Formulation and total need confirmation.
- Availability
- Public materials give different coverage figures. Confirm your state and specific service.
- Treatment formats
- Online evaluation and prescription fulfillment when clinically appropriate.
Ask for the initial and recurring charges in writing. General starting prices do not identify a specific prescription.
In this review
Get a quote for the actual medication
The homepage advertises a $125 monthly starting price. The New Jersey page advertises $149 as a general starting price and lists semaglutide from $299 and tirzepatide from $349 monthly. When comparing recurring costs, ask which product, supply and services are included. The public prices do not establish what you would pay.
Identify your clinician and pharmacy
The terms name OmniRx Management LLC as the platform operator and describe a separate relationship with the treating clinician. MEDGm, for comparison, identifies OpenLoop in its published clinical-care disclosure. Use the pharmacy verification checklist once you have the dispensing facility and exact preparation. Verify availability for your address and keep any research-use listing separate from a prescription quote.
Confirm when benefits and billing stop
The terms set different rules for appointment cancellations and subscriptions. When checking cancellation and refunds, ask for the next billing date and the date access ends. The terms describe cancellation at the end of the billing period but also say subscription benefits expire immediately on cancellation.
What stands out
- Publishes appointment and subscription terms separately
- Identifies the platform operator
What to check
- General entry prices differ from drug-specific examples
- Confirm dispensing pharmacy and when subscription benefits end
Sources and review scope
Public information checked in November 2026. Prices and eligibility can change. We have not enrolled in treatment, independently tested medications or verified the licenses of the clinicians and pharmacies involved in an individual prescription. Compounded medications are not FDA-approved; studies of approved brands do not establish that a compounded product has the same safety or effectiveness.